Platelet‐derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma

Tadahiko Kubo(Memorial Sloan Kettering Cancer Center), Richard Görlick(Albert Einstein College of Medicine)

Cancer

March 13, 2008

10.1002/cncr.23437

Cited by 114

Related Papers

HHLA2, a member of the B7 family, is expressed in human osteosarcoma and is associated with metastases and worse survival

|Scientific Reports|2016|106

R1507, a fully human monoclonal antibody targeting IGF‐1R, is effective alone and in combination with rapamycin in inhibiting growth of osteosarcoma xenografts

|Pediatric Blood & Cancer|2010|82